Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Gilead to Pay Merck $200 Million in Damages Over Hepatitis C Drug Patents
Gilead to Pay Merck $200 Million in Damages Over Hepatitis C Drug Patents
Gilead to Pay Merck $200 Million in Damages Over Hepatitis C Drug Patents
Submitted by
admin
on March 25, 2016 - 9:42am
Source:
WSJ Online
News Tags:
Gilead Sciences
Harvoni
Sovaldi
hepatitis C
Merck
Headline:
Gilead to Pay Merck $200 Million in Damages Over Hepatitis C Drug Patents
Do Not Allow Advertisers to Use My Personal information
